Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | HBB | P68871 | 1/20 | 0.33 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL524165 | 0.79 | LMNA (0.36) | KDM4EMAPTALOX15ALDH1A1GMNN | |
| SCHEMBL3697545 | 0.79 | RECQL (0.56) | MAPTTSHRMEN1KMT2AMAPK1 | |
| SCHEMBL8608172 | 0.79 | TSHR (0.33) | TSHRMEN1KMT2AMAPK1 | |
| Ammonia Solution, Strong SCHEMBL9784969 | 0.77 | TSHR (0.32) | TSHRMEN1KMT2AMAPK1 | |
| SCHEMBL125497 | 0.75 | — | — | |
| SCHEMBL3424967 | 0.75 | KDM4E (0.50) | KDM4EMAPTALOX15ALDH1A1TSHR | |
| SCHEMBL28394791 | 0.75 | KDM4E (0.50) | KDM4EMAPTALOX15ALDH1A1TSHR | |
| SCHEMBL27832263 | 0.75 | CA1 (0.35) | KDM4EALOX15ALDH1A1TSHRLMNA | |
| SCHEMBL7750776 | 0.73 | — | — | |
| Ammonia Solution, Strong SCHEMBL27752877 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102088947-B | Based on compositions and the application thereof of polymer/hydrogen peroxide complexes | L'OREAL (FR) | 2015-07-29 | — | — | CN | disclosed |
| CN-102088947-A | Compositions based on polymer/hydrogen peroxide complexes and uses thereof | OREAL | 2011-06-08 | — | — | CN | disclosed |
| US-20110059035-A1 | COMPOSITIONS BASED ON POLYMER/HYDROGEN PEROXIDE COMPLEXES AND USES THEREOF | L"OREAL | 2011-03-10 | — | — | US | disclosed |
| US-20100112100-A1 | COMPOSITIONS COMPRISING A C-GLYCOSIDE COMPOUND | L'OREAL (FR) | 2010-05-06 | — | — | US | disclosed |
| US-20090018200-A1 | COMPOSITION CONTAINING A PHENANTHRENOL | L'OREAL (FR) | 2009-01-15 | — | — | US | disclosed |
| US-20080226756-A1 | COMPOSITIONS COMPRISING A C-GLYCOSIDE COMPOUND | L'OREAL (FR) | 2008-09-18 | — | — | US | disclosed |
| US-5728389-A | Solid composition for cleansing the skin, containing a particulate structuring agent | L'OREAL (FR) | 1998-03-17 | — | — | US | disclosed |
| US-4695395-A | SODIUM ISETHIONATE | LEVER BROTHERS COMPANY (US) | 1987-09-22 | — | — | US | disclosed |
| US-4180470-A | WEAR RESISTANCE | LEVER BROTHERS COMPANY (US) | 1979-12-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080226756-A1 | COMPOSITIONS COMPRISING A C-GLYCOSIDE COMPOUND | UGCG, GANC, CUTA | KDM4E 1043/4885MAPT 2919/4885ALOX15 4090/4885 |
| US-20090018200-A1 | COMPOSITION CONTAINING A PHENANTHRENOL | CUTA, AHR, TYR | KDM4E 1101/4885MAPT 1889/4885ALOX15 1902/4885 |
| US-20100112100-A1 | COMPOSITIONS COMPRISING A C-GLYCOSIDE COMPOUND | UGCG, GANC, CUTA | KDM4E 1043/4885MAPT 2919/4885ALOX15 4090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.